Javascript must be enabled to continue!
Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest
View through CrossRef
Background—
Patients with Brugada syndrome who were resuscitated from an episode of ventricular fibrillation are at high risk for recurrent sudden death. There is general agreement about the therapeutic strategy for these patients. Conversely, the prognosis and approach in patients with a diagnostic ECG but without a previous history of sudden cardiac death is controversial. We analyzed a large cohort of patients with Brugada syndrome without previous cardiac arrest to understand the determinants of prognosis.
Methods and Results—
A total of 547 patients with an ECG diagnostic of Brugada syndrome and no previous cardiac arrest were studied. The mean age was 41±15 years, and 408 were male. The diagnostic ECG was present spontaneously in 391 patients. In the remaining 156 individuals, the abnormal ECG was noted only after the administration of an antiarrhythmic drug. One hundred twenty-four patients had suffered from at least 1 episode of syncope. During programmed ventricular stimulation, a sustained ventricular arrhythmia was induced in 163 of 408 patients. During a mean follow-up of 24±32 months, 45 patients (8%) suffered sudden death or documented ventricular fibrillation. Multivariate analysis identified the inducibility of a sustained ventricular arrhythmia (
P
<0.0001) and a history of syncope (
P
<0.01) as predictors of events. Logistic regression analysis showed that a patient with a spontaneously abnormal ECG, a previous history of syncope, and inducible sustained ventricular arrhythmias had a probability of 27.2% of suffering an event during follow-up.
Conclusions—
Individuals with Brugada syndrome and no previous cardiac arrest have a high risk of sudden death. Inducibility of ventricular arrhythmias and a previous history of syncope are markers of a poor prognosis.
Ovid Technologies (Wolters Kluwer Health)
Title: Determinants of Sudden Cardiac Death in Individuals With the Electrocardiographic Pattern of Brugada Syndrome and No Previous Cardiac Arrest
Description:
Background—
Patients with Brugada syndrome who were resuscitated from an episode of ventricular fibrillation are at high risk for recurrent sudden death.
There is general agreement about the therapeutic strategy for these patients.
Conversely, the prognosis and approach in patients with a diagnostic ECG but without a previous history of sudden cardiac death is controversial.
We analyzed a large cohort of patients with Brugada syndrome without previous cardiac arrest to understand the determinants of prognosis.
Methods and Results—
A total of 547 patients with an ECG diagnostic of Brugada syndrome and no previous cardiac arrest were studied.
The mean age was 41±15 years, and 408 were male.
The diagnostic ECG was present spontaneously in 391 patients.
In the remaining 156 individuals, the abnormal ECG was noted only after the administration of an antiarrhythmic drug.
One hundred twenty-four patients had suffered from at least 1 episode of syncope.
During programmed ventricular stimulation, a sustained ventricular arrhythmia was induced in 163 of 408 patients.
During a mean follow-up of 24±32 months, 45 patients (8%) suffered sudden death or documented ventricular fibrillation.
Multivariate analysis identified the inducibility of a sustained ventricular arrhythmia (
P
<0.
0001) and a history of syncope (
P
<0.
01) as predictors of events.
Logistic regression analysis showed that a patient with a spontaneously abnormal ECG, a previous history of syncope, and inducible sustained ventricular arrhythmias had a probability of 27.
2% of suffering an event during follow-up.
Conclusions—
Individuals with Brugada syndrome and no previous cardiac arrest have a high risk of sudden death.
Inducibility of ventricular arrhythmias and a previous history of syncope are markers of a poor prognosis.
Related Results
Brugada Syndrome
Brugada Syndrome
AbstractBrugada syndrome (BrS) is characterised by right bundle branch block and persistent ST‐segment elevation in right precordial leads. It is responsible for 4–12% of total sud...
Abstract 4138514: From Treatment to Trigger: A Case of Atomoxetine-Induced Brugada Pattern
Abstract 4138514: From Treatment to Trigger: A Case of Atomoxetine-Induced Brugada Pattern
Introduction:
Brugada syndrome is an inherited cardiac disorder characterized by specific ECG patterns, notably the coved-type ST-segment elevation in the right precord...
Prognostic Value of Electrophysiologic Investigations in Brugada Syndrome
Prognostic Value of Electrophysiologic Investigations in Brugada Syndrome
Brugada Syndrome.
Introduction: The prognostic value of electrophysiologic investigations in individuals with Brugada syndrome is unclear. Previous studies failed to dete...
Electrocardiographic Effects of Propofol versus Etomidate in Patients with Brugada Syndrome
Electrocardiographic Effects of Propofol versus Etomidate in Patients with Brugada Syndrome
Abstract
Background
Brugada Syndrome is an inherited arrhythmogenic disease, characterized by the typical coved type ST-segment elevation in the ...
Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
Brugada syndrome is a rare inherited arrhythmogenic disease leading to ventricular fibrillation and high risk of sudden death. In 1998, this syndrome was linked with a genetic vari...
Low-dose oral flecainide provocation test for Brugada syndrome: a case series
Low-dose oral flecainide provocation test for Brugada syndrome: a case series
Abstract
Background
Brugada syndrome is a rare, inherited cardiac disorder that predisposes individuals to life-threatening ventricular arrhythmi...
Genetic and Molecular Mechanisms in Brugada Syndrome
Genetic and Molecular Mechanisms in Brugada Syndrome
Brugada syndrome is a rare hereditary arrhythmia disorder characterized by a distinctive electrocardiogram pattern and an elevated risk of ventricular arrhythmias and sudden cardia...
Brugada Syndrome and Pregnancy: Highlights on Antenatal and Prenatal Management
Brugada Syndrome and Pregnancy: Highlights on Antenatal and Prenatal Management
Introduction. Brugada syndrome is characterized by a disruption of heart’s normal rhythm. It is an autosomal dominant disease due to a mutation of SNC5A gene. Its prevalence is low...

